Patients with pulmonary hypertension associated with heart failure were less likely to experience clinical worsening when treated with transcatheter pulmonary artery denervation (PADN) compared to receiving medical therapy alone, the results of a randomised trial conducted at 25 sites in China have shown. The study—PADN-HF-PH—sought to evaluate the safety and clinical efficacy of adding PADN […] The post Pulmonary artery denervation shows promise in pulmonary hypertension linked to heart-failure appeared first on Cardiovascular News .